Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-078197

Options or other derivatives

  • Director acquired 547,296 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Allen Andrew R Director 2023-07-05 Grant or award · Option to Purchase Ordinary Shares +73,212 73,212 D
Allen Andrew R Director 2023-07-05 Grant or award · Option to Purchase Ordinary Shares +56,868 56,868 D
Allen Andrew R Director 2023-07-05 Grant or award · Option to Purchase Ordinary Shares +45,348 45,348 D
Allen Andrew R Director 2023-07-05 Grant or award · Option to Purchase Ordinary Shares +109,746 109,746 D
Allen Andrew R Director 2023-07-05 Grant or award · Option to Purchase Ordinary Shares +109,746 109,746 D
Allen Andrew R Director 2023-07-05 Grant or award · Option to Purchase Ordinary Shares +152,376 152,376 D
Loading xslF345X04/tm2320409-9_4seq1.xml…